Angie Cheng (she/her/hers)

Director of R&D
Thermo Fisher Scientific
Austin, Texas, United States

Angie Cheng is currently a Director of R&D at Thermo Fisher Scientific leading an R&D organization that is developing NGS-related sample preparation and sequencing kits and workflows for solid tumor and liquid biopsy testing. She has over 20+ years working in the Life Sciences industry developing and commercializing products supporting collaborations and innovation. Her team most recently developed and validated the FDA approved Oncomine Dx Express Test.

Disclosure information not submitted.

Presentation(s):

• Exploring EGFR exon 20 insertions in NSCLC and the FDA-approved Oncomine Dx Express Test for CDx and tumor profiling

  Wednesday, November 12, 2025
  9:00 AM - 9:50 AM EST